Latest News
Press background on Rajiv Gandhi Cancer Institute and Research Centre
Company profile
Rajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer the unique advantage of cutting edge technology, put to use by renowned super-specialists. Ever since its inception, RGCIRC has taken care of over 2 Lakh patients. RGCIRC has earned repute across India as well as internationally for its services in the field of oncology, haematology and bone marrow transplantation.
 Recent press releases
RGCON 2022 Turns the Spotlight on Urological Cancers

The 20th edition of RGCON, the annual international conference of Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) Delhi will be held on the theme of “Frontiers in Uro Oncology” on 15th, 16th and 17th April, 2022 at New Delhi. In tandem with the multimodal approach being used ... (more)
Share
RGCON 2020 Focussed on Hemato-Oncology Update

RGCON 2020, the 19th Annual International Conference of Rajiv Gandhi Cancer Institute and Research Centre to be held in New Delhi from 7th - 9th February 2020 is focused on an all-important aspect of Hemato-oncology Update. Haematology-oncology includes such diseases as Leukaemia, Lymphoma, Myeloma... (more)
Share